Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 12, 2019 at 10:13 pm IST
Share
BioLASCO Taiwan Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 61.133 million compared to TWD 111.835 million a year ago. Operating income was TWD 13.433 million compared to TWD 34.017 million a year ago. Net income was TWD 11.303 million compared to TWD 26.284 million a year ago. Basic earnings per share was TWD 0.44 compared to TWD 1.13 a year ago. For the nine months, sales was TWD 283.729 million compared to TWD 222.050 million a year ago. Operating income was TWD 57.669 million compared to TWD 59.300 million a year ago. Net income was TWD 45.458 million compared to TWD 45.714 million a year ago. Basic earnings per share was TWD 1.82 compared to TWD 1.96 a year ago.
BioLASCO Taiwan Co., Ltd. is a Taiwan-based company mainly engaged in the production of Specific Pathogen Free (SPF) laboratory animals and the high-value special-mode experimental animals, as well as the introduction and production of highly-applicable disease-mode animals. The company also provides equipment related to feeding, supplies and testing platform, life science research and pharmaceutical development services.